Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Recruiting 6Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Breast 2Thoracic 1Head & Neck 1Gynecologic 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Thymoma 1Neoplasms 1Endometrial Neoplasms 1Carcinoma, Lobular 1

Interventions

Specimen Handling 481pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 239Paclitaxel 226Gemcitabine 222Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 165Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 142Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Radiotherapy, Adjuvant × 1 year × Clear all
NCT07613151 2026-05-29

NAPOLI

Istituto Oncologico Veneto IRCCS

Recruiting
250 enrolled

Neoplasms, Carcinoma, Lobular

NCT06897488 2026-05-15

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

M.D. Anderson Cancer Center

Phase 2 Recruiting
300 enrolled
Breast

Breast Neoplasms

NCT05640999 2026-05-12

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Canadian Cancer Trials Group

Phase 2 Recruiting
393 enrolled
Gynecologic

Endometrial Neoplasms

NCT02633553 2026-04-24

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Fudan University

Phase NA Recruiting
238 enrolled
Thoracic

Thymoma

NCT06524167 2026-02-27

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Fudan University

Recruiting
80 enrolled
Head & Neck

Thyroid Neoplasms

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Xijing Hospital

Phase 2 Recruiting
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡